Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Cancer Research Communications|March 16, 2023
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of MegakaryocytesCindy Lin, Laura Garcia-Gerique, Erin E Bonner, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceBrad H Rovin, Dawn J Caster, Daniel C Cattran, et al.
Blood|September 19, 2015
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myelomaJatin J Shah, Edward A Stadtmauer, Rafat Abonour, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient miceZainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With MyelomaThomas M Paul, Stephen V Liu, Elise A Chong, et al.
JCI Insight|May 7, 2024
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient miceZainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
Cancer Research|September 7, 2022
A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor ProgressionHui Deng, Cindy Lin, Laura Garcia-Gerique, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Autophagy|July 4, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myelomaDan T Vogl, Edward A Stadtmauer, Kay-See Tan, et al.
Pageof 11